• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

cushing-and-endogenous-hypercortisolism.com
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home 2024 February 26

Post Archive by Day

View Post

Risk Profile IDs COVID-19 Patients Who Will Benefit From Baricitinib

In COVID-19, Latest News
by Healthday
February 26, 2024

Baricitinib plus remdesivir linked to reduced risk of death, progression to invasive mechanical ventilation

View Post

Youth Antidepressant Prescribing Rose Faster After COVID-19 Outbreak

In COVID-19, Latest News
by Healthday
February 26, 2024

Rate increased by 17.0 percent per month before March 2020; increased 63.5 percent faster from March 2020 onward

View Post

Observed Rates of Cancer Diagnoses Lower Than Expected in Pandemic

In COVID-19, Latest News
by Healthday
February 26, 2024

Rate of all-sites cancer incidence was 28.6 percent lower than expected during the height of the COVID-19 pandemic response

TRENDING

  • Malaria Monoclonal Antibody Provides Some Protection
  • New World Screwworm Confirmed in Nuevo Leon
  • UK Vaccination Campaign Protects Newborns this Winter
  • Should Canada and Mexico Visitors Verify Measles Immunity
  • New Vaccine Panel Recommends Doctor Consults Before COVID Shots

By Publish Date

February 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
26272829  
« Jan   Mar »

LATEST ARTICLES

  • Malaria Monoclonal Antibody Provides Some Protection September 25, 2025
  • New World Screwworm Confirmed in Nuevo Leon September 22, 2025
  • UK Vaccination Campaign Protects Newborns this Winter September 22, 2025

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines
eHealthcare Solutions (EHS) manages advertising on this website. We use cookies to ensure that we give you the best experience on our website. By continuing, you agree to the use of cookies as per the EHS Privacy Policy